Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Diaphragmatic Function After Interscalene Brachial Plexus Block With Liposomal Bupivacaine
NCT07263295Recruiting
- Sponsor
- Zhejiang University
- Start
- Dec 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of liposomal bupivacaine in metacarpal fracture, radius fracture, chronic ulcer and 1 more (2 arms), sponsored by Zhejiang University. Primary endpoint: Recovery time of diaphragmatic function after diaphragmatic paralysis caused by interscalene brachial plexus block at 72 hours. Started Dec 2025; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
metacarpal fractureradius fracturechronic ulcerLigament injury of upper limb
Beyond the preview
Go deeper on NCT07263295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07263295.